Fernanda Khouri Barreto

Prof. Dr. Fernanda Khouri Barreto

Federal University of Bahia, Brazil
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
TATalita Adelino
Talita Adelino
Marta GiovanettiMarta Giovanetti
Marta Giovanetti
Vagner FonsecaVagner Fonseca
Vagner Fonseca
JXJoilson Xavier
Joilson Xavier
ÁAÁlvaro Salgado de Abreu
Álvaro Salgado de Abreu
LALuiz Carlos Junior Alcantara
Luiz Carlos Junior Alcantara
Brazil experienced a large dengue virus (DENV) epidemic in 2019, highlighting a continuous struggle with effective control and public health preparedness. Using Oxford Nanopore sequencing, we led field and classroom initiatives for the monitoring of DENV in Brazil, generating 227 novel genome sequences of DENV1-2 from 85 municipalities (2015–2019). This equated to an over 50% increase in the number of DENV genomes from Brazil available in public databases. Using both phylogenetic and epidemiological models we retrospectively reconstructed the recent transmission history of DENV1-2. Phylogenetic analysis revealed complex patterns of transmission, with both lineage co-circulation and replacement. We identified two lineages within the DENV2 BR-4 clade, for which we estimated the effective reproduction number and pattern of seasonality. Overall, the surveillance outputs and training initiative described here serve as a proof-of-concept for the utility of real-time portable sequencing for research and local capacity building in the genomic surveillance of emerging viruses.

12 April 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
AQAdriano Queiroz
Adriano Queiroz
IPIsabella Fernanda Dantas Pinto
Isabella Fernanda Dantas Pinto
MLMaricélia Lima
Maricélia Lima
MGMarta Giovanetti
Marta Giovanetti
JJJaqueline Goes de Jesus
Jaqueline Goes de Jesus
LALuiz Carlos Junior Alcantara
Luiz Carlos Junior Alcantara
Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the Flavivirus genus of the Flaviviridae family. Since the large outbreaks in French Polynesia in 2013–2014 and in Brazil in 2015, ZIKV has been considered a new public health threat. Similar to other related flavivirus, ZIKV is associated with mild and self-limiting symptoms such as rash, pruritus, prostration, headache, arthralgia, myalgia, conjunctivitis, lower back pain and, when present, a short-term low grade fever. In addition, ZIKV has been implicated in neurological complications such as neonatal microcephaly and Guillain–Barré syndrome in adults. Herein, serum lipidomic analysis was used to identify possible alterations in lipid metabolism triggered by ZIKV infection. Patients who presented virus-like symptoms such as fever, arthralgia, headache, exanthema, myalgia and pruritus were selected as the control group. Our study reveals increased levels of several phosphatidylethanolamine (PE) lipid species in the serum of ZIKV patients, the majority of them plasmenyl-phosphatidylethanolamine (pPE) (or plasmalogens) linked to polyunsaturated fatty acids. Constituting up to 20% of total phospholipids in humans, plasmalogens linked to polyunsaturated fatty acids are particularly enriched in neural membranes of the brain. The biosynthesis of plasmalogens requires functional peroxisomes, which are important sites for viral replication, including ZIKV. Thus, increased levels of plasmalogens in serum of ZIKV infected subjects suggest a link between ZIKV life cycle and peroxisomes. Our data provide important insights into specific host cellular lipids that are likely associated with ZIKV replication and may serve as platform for antiviral strategy against ZIKV.

17 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
QFQesya Rodrigues Ferreira
Qesya Rodrigues Ferreira
FLFabian Fellipe Bueno Lemos
Fabian Fellipe Bueno Lemos
MMMatheus Moura
Matheus Moura
JNJéssica Oliveira de Souza Nascimento
Jéssica Oliveira de Souza Nascimento
ANAna Flávia Novaes
Ana Flávia Novaes
FMFabrício De melo
Fabrício De melo
Aedes aegypti and Aedes albopictus are the vectors of important arboviruses: dengue fever, chikungunya, Zika, and yellow fever. Female mosquitoes acquire arboviruses by feeding on the infected host blood, thus being able to transmit it to their offspring. The intrinsic ability of a vector to infect itself and transmit a pathogen is known as vector competence. Several factors influence the susceptibility of these females to be infected by these arboviruses, such as the activation of the innate immune system through the Toll, immunodeficiency (Imd), JAK-STAT pathways, and the interference of specific antiviral response pathways of RNAi. It is also believed that the presence of non-pathogenic microorganisms in the microbiota of these arthropods could influence this immune response, as it provides a baseline activation of the innate immune system, which may generate resistance against arboviruses. In addition, this microbiome has direct action against arboviruses, mainly due to the ability of Wolbachia spp. to block viral genome replication, added to the competition for resources within the mosquito organism. Despite major advances in the area, studies are still needed to evaluate the microbiota profiles of Aedes spp. and their vector competence, as well as further exploration of the individual roles of microbiome components in activating the innate immune system.

13 February 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
CSCarolina Souza Santana
Carolina Souza Santana
FAFelipe de Oliveira Andrade
Felipe de Oliveira Andrade
GSGreice Carolina Santos da Silva
Greice Carolina Santos da Silva
JNJéssica Oliveira de Souza Nascimento
Jéssica Oliveira de Souza Nascimento
RCRaissa Frazão Campos
Raissa Frazão Campos
FBFernanda Khouri Barreto
Fernanda Khouri Barreto
Introduction: The Human T-lymphotropic virus type 1 (HTLV-1) was the first described human retrovirus. It is currently estimated that around 5 to 10 million people worldwide are infected with this virus. Despite its high prevalence, there is still no preventive vaccine against the HTLV-1 infection. It is known that vaccine development and large-scale immunization play an important role in global public health. To understand the advances in this field we performed a systematic review regarding the current progress in the development of a preventive vaccine against the HTLV-1 infection.Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA®) guidelines and was registered at the International Prospective Register of Systematic Reviews (PROSPERO). The search for articles was performed in PubMed, Lilacs, Embase and SciELO databases. From the 2,485 articles identified, 25 were selected according to the inclusion and exclusion criteria.Results: The analysis of these articles indicated that potential vaccine designs in development are available, although there is still a paucity of studies in the human clinical trial phase.Discussion: Although HTLV-1 was discovered almost 40 years ago, it remains a great challenge and a worldwide neglected threat. The scarcity of funding contributes decisively to the inconclusiveness of the vaccine development. The data summarized here intends to highlight the necessity to improve the current knowledge of this neglected retrovirus, encouraging for more studies on vaccine development aiming the to eliminate this human threat.Systematic review registration: https://www.crd.york.ac.uk/prospero, identifier (CRD42021270412).

1 November 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
FBFernanda Khouri Barreto
Fernanda Khouri Barreto
RKRicardo Khouri
Ricardo Khouri
FRFilipe Ferreira de Almeida Rego
Filipe Ferreira de Almeida Rego
LSLuciane Amorim Santos
Luciane Amorim Santos
MAMaria Fernanda Castro Amarante
Maria Fernanda Castro Amarante
LALuiz Carlos Junior Alcantara
Luiz Carlos Junior Alcantara

6 March 2013 in Virology Journal
Verified
Journal Article
Open access
PDF file
AMAline C A Mota-Miranda
Aline C A Mota-Miranda
FBFernanda Khouri Barreto
Fernanda Khouri Barreto
MAMaria F C Amarante
Maria F C Amarante
EBEverton Batista
Everton Batista
JMJoana P Monteiro-Cunha
Joana P Monteiro-Cunha
LALuiz Carlos Junior Alcantara
Luiz Carlos Junior Alcantara
Background: Human T-cell Leukemia Virus type 1 (HTLV-1) is the etiological agent of tropical spastic paraparesis/HTLV-associated myelopathy (HAM/TSP) that can be identified in around 0.25%–3.8% of the infected population. Disease progression can be monitored by the proviral load and may depend on genetic factors, however, it is not well understood why some HTLV-1 infected people develop the disease while others do not. The present study attempts to assess the molecular diversity of gp46 glycoprotein in HAM/TSP patients and Health Carrier (HC) individuals.Methods: Blood samples were collected from 10 individuals, and DNA was extracted from PBMCs to measure the HTLV-1 proviral load. The gp46 coding sequences were amplified PCR, cloned and sequenced. The molecular characterization was performed using bioinformatics tools.Results: The median HTLV-1 proviral load of HC (n = 5) and HAM/TSP (n = 5) patients was similar (average 316,227 copies/106PBMCs). The gp46 molecular characterization of 146 clones (70 HC and 76 HAM/TSP) revealed an overall diversity, within HC and HAM/TSP clones, of 0.4% and 0.6%, respectively. Five frequent mutations were detected among groups (HAM/TSP and HC clone sequences). A single amino acid (aa) substitution (S35L) was exclusive for the HC group, and three gp46 substitutions (F14S, N42H, G72S) were exclusive for the HAM/TSP group. The remaining frequent mutation (V247I) was present in both groups (p = 0.0014). The in silico protein analysis revealed that the mutated alleles F14S and N42H represent more hydrophilic and flexible protein domains that are likely to be less antigenic. The Receptor Binding Domain is quite variable in the HAM/TSP group. Two other domains (aa 53–75 and 175–209) that contain multiple linear T-cell epitopes showed genetic diversity in both HAM/TSP and HC groups. Further analysis revealed 27 and 13 T-cell epitopes for class I HLA alleles and class II HLA alleles, when analyzing the entire gp46.Conclusions: The most common gp46 mutations were not associated clinical status because they were found in only one individual, except for the V247I mutation, that was found at viral clones from HAM/TSP ad HC individuals. Because of this, we cannot associate any of the gp46 found mutations with the clinical profile.